Assessment of Weight Loss With the Intragastric Balloon in Patients With Different Degrees of Obesity. Issue 4 (August 2017)

• Record Type: Journal Article
• Authors: Nunes, Gabriel C.; Pajecki, Denis; de Melo, Maria E.; Mancini, Marcio C.; de Cleva, Roberto; Santo, Marco A.
• Is Part Of: Surgical laparoscopy endoscopy & percutaneous techniques. Volume 27:Issue 4(2017)
• Publication Date: 2017-08
• Subjects: obesity -- treatment -- endoscopy -- gastric balloon; Endoscopic surgery -- Periodicals; Laparoscopic surgery -- Periodicals; Endoscopy -- Periodicals; Laparoscopy -- Periodicals; 617.550597
• DOI: 10.1097/SLE.0000000000000440
• Languages: English
• ISSNs: 1530-4515

Abstract

Abstract : Introduction: The intragastric balloon (IGB) is an endoscopic device for the treatment of obesity. Best results are observed in patients who follow a dietary program but few studies have assessed the results of this treatment in patients with different degrees of obesity. Aim: The aim of this study is to compare the efficacy of IGB in patients with different degrees of obesity. Method: A total of 2002 patients with IGB were retrospectively evaluated and were divided into groups according to initial body mass index (BMI) range, as follows: group 1, 27 to 29.9 kg/m 2 ; group 2, 30 to 34.9 kg/m 2 ; group 3, 35 to 39.9 kg/m 2 ; group 4, 40 to 44.9 kg/m 2 ; group 5, ≥45 kg/m 2 . Weight was assessed in 3 different times: before (T0), 1 month (T1), 6 months (T2), and 6 months after removal of the IGB (T3). Results: A total of 946 patients lost follow-up. Overall, 40 (3.78%) removed the device before programmed by intolerance, and 1016 patients completed the 6-month treatment. The mean weight loss was 18.9%, excess weight loss 60.1% and an BMI reduction of 6.76 points. 6 months after removal of the balloon 842 patients had continued follow-up (82.8%). At this time, weight loss was 19.84%, excess weight loss was 59.49%, and BMI reduction of 7.06 points. In all groups there was statistical difference between the times T0 and T1 and between T1 and T2 ( P <0.001). There was no statistical difference between T2 and T3, in any group. Conclusion: IGB provided sustained weight loss in patients who remained in dietary follow-up for 1 year.